コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 responses than Zaire Ebola virus (ZEBOV) or Marburg virus.
2 entified in Ebola virus GP1 are conserved in Marburg virus.
3 se caused by the filoviruses Ebola virus and Marburg virus.
4 osure of rhesus macaques to a lethal dose of Marburg virus.
5 ected primates respond following exposure to Marburg virus.
6 strategies against infections with Ebola and Marburg viruses.
7 for the largest outbreak ever documented for Marburg viruses.
9 completely protect nonhuman primates against Marburg virus and 3 different species of Ebola virus.
10 t virus, Bundibugyo virus, Reston virus, and Marburg virus and differentiated between the genera Ebol
12 typed with Marburg virus GP(1,2), as well as Marburg virus and Ebola virus infection in a dose-depend
13 sembled using filovirus matrix proteins from Marburg virus and Ebola virus is also sensitive to inhib
16 re likely induced in response to exposure to Marburg virus and further suggested that the early immun
17 ndibugyo virus (BDBV), Sudan virus, and even Marburg virus and Lloviu virus, which belong to the hete
20 n, Tai Forest, Bundibugyo, Zaire, Sudan, and Marburg viruses and found two antibodies that showed pan
25 uctures and visual images of the proteins of Marburg virus are essential for the development of antiv
27 onstrate that the VP35s from Ebola virus and Marburg virus are the major suppressors of DC maturation
31 re resistant to infection by Ebola virus and Marburg virus, but remain fully susceptible to a suite o
39 To better understand the overall response to Marburg virus challenge, we undertook a transcriptomic a
40 the Ravn strain (RAVV VP40)-from a distinct Marburg virus clade-is demonstrated to also inhibit IFN
46 e, we present the 3.6 A crystal structure of Marburg virus GP in complex with a cross-reactive antibo
47 bited entry of retroviruses pseudotyped with Marburg virus GP(1,2), as well as Marburg virus and Ebol
48 tro potency of CV-N to inhibit EboZV GP- and Marburg virus GP-pseudotyped viruses (EC50 approximately
49 s highly similar to those of Ebola virus and Marburg virus GP2 despite CASV genome homology to arenav
50 ructure has been observed in Ebola virus and Marburg virus GP2, as well as other viruses that enter v
51 uring mouse adaptation of the Ravn strain of Marburg virus have impacted the budding function of the
52 filoviruses including Sudan, Bundibugyo, and Marburg viruses have caused human outbreaks with mortali
53 herapeutics are licensed to counter Ebola or Marburg viruses, highly pathogenic filoviruses that are
54 omologous protection against Ebola virus and Marburg virus in a prophylactic setting against in macaq
56 are currently no approved interventions for Marburg virus, in part because a small-animal model that
57 ar requirements of nucleocapsid transport in Marburg virus-infected cells under biosafety level 4 con
58 nes whose disruption allowed the survival of Marburg virus-infected cells, suggesting that Rab9 is ut
59 ngs demonstrate very early host responses to Marburg virus infection and provide a rich data set for
60 were tested for evidence of acute or recent Marburg virus infection by reverse transcription-polymer
61 study, we carefully analyzed the timeline of Marburg virus infection in nonhuman primates in order to
62 We evaluated the susceptibility to Ebola and Marburg virus infection of mice that cannot respond to i
63 completely protects cynomolgus macaques from Marburg virus infection when administered as late as 48
65 own to protect macaques from Ebola virus and Marburg virus infections, both prophylactically and post
68 The findings imply that reservoir hosts of Marburg virus inhabit caves, mines, or similar habitats.
72 ve different viruses, including Ebola virus, Marburg virus, lymphocytic choriomeningitis virus (LCMV)
76 members of the Marburgvirus genus, including Marburg virus (MARV) and Ravn virus (RAVV), is difficult
84 In the seven protein-coding genes in the Marburg virus (MARV) genome, the synonymous nucleotide d
88 n virus (SUDV), Bundibugyo virus (BDBV), and Marburg virus (MARV) have also caused sizeable human out
89 dated as an inhibitor of infectious EBOV and Marburg virus (MARV) in cell-based assays, with 50% inhi
100 e particles (VLPs) of Ebola virus (EBOV) and Marburg virus (MARV) produced in human 293T embryonic ki
101 2 closely related plaque-derived variants of Marburg virus (MARV) species Lake Victoria marburgvirus,
103 that the filoviruses Ebola virus (EBOV) and Marburg virus (MARV) suppress DC maturation in vitro Bot
104 s, we delivered an antigen-capture assay for Marburg virus (MARV) that was based on llama single-doma
108 iruses, consisting of Ebola virus (EBOV) and Marburg virus (MARV), are among the most lethal infectio
109 ruses, including both Ebola virus (EBOV) and Marburg virus (MARV), can infect humans and other animal
112 re highly conserved among filoviruses except Marburg virus (MARV), suggesting that MARV may not bind
113 oding the glycoprotein (GP) gene from Angola Marburg virus (MARV), were compared for their ability to
119 te bat (ERB) is a natural reservoir host for Marburg virus (MARV); however, the mechanisms by which M
120 f lethal infection with the Angola strain of Marburg virus (MARV-Ang) in rhesus macaques and tested t
122 ) and nucleoprotein (NP) of Ebola (EBOV) and Marburg viruses (MARV) play key roles during virion asse
126 he putative matrix protein of both Ebola and Marburg viruses, possesses a conserved proline-rich moti
127 ]R downward arrow), and one is predicted for Marburg viruses (R[R/K]KR downward arrow), although in a
128 that the VP40 protein of the Ravn strain of Marburg virus (Ravn virus [RAVV]) failed to block IFN si
131 e ZEBOV and Sudan Ebolavirus and 4 different Marburg virus strains produced severe, but more slowly p
132 roup received the same dose of the VSV-based Marburg virus vaccine at both time points; another group
135 ays, including Ebola virus VP35 and VP24 and Marburg virus VP35, VP40, and VP24, on DC maturation and
136 the corresponding (84)LPLGIM(89) sequence of Marburg virus VP40 (mVP40) are critical for efficient re
138 Here we provide the molecular structure of Marburg virus VP40, illustrate differences from VP40 of
140 using in vitro affinity reagent selection on Marburg virus we rapidly established monoclonal affinity
141 an completely protect rhesus monkeys against Marburg virus when administered after exposure and can p
142 virus, Lassa virus, LCMV, rabies virus, and Marburg virus, which was substituted for the VSV glycopr
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。